De Motu Cordis
Dry Powder Inhaler

A platform inhaler technology currently under development, intended to deliver dry powder drug formulations to the lungs for therapeutic purposes

Product
Pulmonary Pathway Delivery
The IH1 is being developed to utilise the pulmonary pathway to deliver drug formulations to patients in need.

Partnership
Device Optimisation
Our industrial design team collaborated with the DMC engineering team to refine the prototype device.

[It has] Been a pleasure working with the Ingenuity team. All work delivered has been of a high level and the team has delivered on often tight timelines.
Ben Trout
Device Project Leader,
De Motu Cordis
De Motu Cordis
Pocket Sized Potential


Caution: New Drug-Device Limited by Federal law to investigational use.
What our clients are saying
Let’s create better, together.
Get in touch to schedule your free initial consultation with our team today!
